Seniors struggling with high pharmacy bills finally receive a major financial lifeline in 2026. A key provision of the Inflation Reduction Act now caps annual out-of-pocket prescription costs at approximately $2,000 for Medicare Part D plans.
No hard limit existed previously, often forcing patients with cancer or arthritis to pay thousands annually. This new rule eliminates the “donut hole” coverage gap. Once copays hit the cap, the plan pays 100 percent of covered drug costs. While this change saves money for those on high-cost medications, it brings trade-offs like potential premium hikes.
